71.62
price up icon0.03%   0.02
after-market アフターアワーズ: 71.68 0.06 +0.08%
loading
前日終値:
$71.60
開ける:
$71.66
24時間の取引高:
3.80M
Relative Volume:
0.82
時価総額:
$11.16B
収益:
$1.21B
当期純損益:
$109.52M
株価収益率:
102.87
EPS:
0.6962
ネットキャッシュフロー:
$269.60M
1週間 パフォーマンス:
-0.03%
1か月 パフォーマンス:
+0.87%
6か月 パフォーマンス:
+4.97%
1年 パフォーマンス:
+21.84%
1日の値動き範囲:
Value
$71.58
$71.88
1週間の範囲:
Value
$71.45
$72.11
52週間の値動き範囲:
Value
$43.20
$72.16

Bio Techne Corp Stock (TECH) Company Profile

Name
名前
Bio Techne Corp
Name
セクター
Healthcare (1074)
Name
電話
612-379-8854
Name
住所
614 MCKINLEY PL N E, MINNEAPOLIS, MN
Name
職員
3,100
Name
Twitter
@biotechne
Name
次回の収益日
2026-08-05
Name
最新のSEC提出書
Name
TECH's Discussions on Twitter

Compare TECH vs VRTX, REGN, ARGX, RVMD, ALNY

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
TECH icon
TECH
Bio Techne Corp
71.62 11.16B 1.21B 109.52M 269.60M 0.6962
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
479.00 121.16B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
667.17 68.78B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
888.82 57.44B 4.16B 1.29B 734.26M 19.58
RVMD icon
RVMD
Revolution Medicines Inc
188.07 40.23B 742.00K -1.37B -1.07B -7.0731
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
278.40 36.28B 4.29B 577.22M 641.34M 4.2086

Bio Techne Corp Stock (TECH) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-09-03 アップグレード RBC Capital Mkts Sector Perform → Outperform
2025-08-21 アップグレード Citigroup Neutral → Buy
2025-07-22 再開されました Stephens Overweight
2025-07-09 開始されました TD Cowen Buy
2025-05-30 開始されました Wells Fargo Overweight
2025-04-09 ダウングレード KeyBanc Capital Markets Overweight → Sector Weight
2025-03-18 開始されました Evercore ISI Outperform
2025-02-19 ダウングレード Robert W. Baird Outperform → Neutral
2024-05-22 ダウングレード Citigroup Buy → Neutral
2024-02-08 開始されました Scotiabank Sector Outperform
2024-02-02 ダウングレード Stifel Buy → Hold
2023-12-07 開始されました UBS Buy
2023-08-28 開始されました William Blair Outperform
2023-01-10 アップグレード Wells Fargo Underweight → Equal Weight
2022-12-14 開始されました Deutsche Bank Buy
2022-12-12 アップグレード Citigroup Neutral → Buy
2022-12-07 開始されました RBC Capital Mkts Sector Perform
2022-08-25 開始されました Credit Suisse Outperform
2022-04-25 ダウングレード Wells Fargo Equal Weight → Underweight
2021-09-15 アップグレード KeyBanc Capital Markets Sector Weight → Overweight
2021-03-08 アップグレード Stephens Equal-Weight → Overweight
2021-02-23 アップグレード Stifel Hold → Buy
2021-01-25 繰り返されました The Benchmark Company Buy
2020-11-10 開始されました KeyBanc Capital Markets Sector Weight
2020-09-30 開始されました Atlantic Equities Overweight
2020-07-15 ダウングレード Stephens Overweight → Equal-Weight
2020-05-27 ダウングレード Stifel Buy → Hold
2020-05-14 開始されました The Benchmark Company Buy
2020-01-08 再開されました Stephens Overweight
2020-01-08 開始されました Wells Fargo Equal Weight
2020-01-07 開始されました Citigroup Neutral
2019-11-15 開始されました Stifel Buy
2019-07-02 アップグレード Janney Neutral → Buy
2019-01-14 アップグレード Stephens Equal-Weight → Overweight
2018-10-31 ダウングレード Craig Hallum Buy → Hold
2018-10-17 開始されました Goldman Neutral
2018-06-15 開始されました Argus Buy
2017-07-13 開始されました Wells Fargo Market Perform
2017-02-09 開始されました Citigroup Buy
2017-01-18 開始されました Deutsche Bank Buy
2016-11-10 再開されました Leerink Partners Outperform
2015-01-21 繰り返されました Robert W. Baird Outperform
2013-09-20 アップグレード Robert W. Baird Neutral → Outperform
すべてを表示

Bio Techne Corp (TECH) 最新ニュース

pulisher
04:03 AM

Bio-Techne Corp (TECH) SVP option exercise and share withholding - Stock Titan

04:03 AM
pulisher
10:53 AM

Bio-Techne Corp (TECH) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

10:53 AM
pulisher
03:31 AM

Bio-Techne Corp (TECH) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

03:31 AM
pulisher
Jul 26, 2026

TECH|Bio-Techne Corp|Price:71.600|Chg%:-0.170 - TradingKey

Jul 26, 2026
pulisher
Jul 25, 2026

Bio-Techne Corp (TECH) Institutional Confidence - TradingKey

Jul 25, 2026
pulisher
Jul 25, 2026

Bio-Techne Corp Revenue Breakdown – NASDAQ:TECH - TradingView

Jul 25, 2026
pulisher
Jul 24, 2026

Bio-Techne Corp (TECH) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jul 24, 2026
pulisher
Jul 20, 2026

What to Expect From Bio-Techne's Next Quarterly Earnings Report - Barchart.com

Jul 20, 2026
pulisher
Jul 16, 2026

(TECH) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily

Jul 16, 2026
pulisher
Jul 16, 2026

Q1 Earnings Outperformers: Bio-Techne (NASDAQ:TECH) And The Rest Of The Research Tools & Consumables Stocks - Yahoo Finance

Jul 16, 2026
pulisher
Jul 14, 2026

Bio-Techne Corp (TECH) Hovers Near Support Amid Modest DeclinePCR Spike - dars.gov.et

Jul 14, 2026
pulisher
Jul 13, 2026

Bio-Techne Corp (TECH) Stock Analysis: Navigating the Biotechnology Landscape Amidst Revenue Challenges - DirectorsTalk Interviews

Jul 13, 2026
pulisher
Jul 09, 2026

Bio-Techne Corp (TECH) Holds Steady Near Support as Slight Gains Signal StabilizationAI Trade Signals - dars.gov.et

Jul 09, 2026
pulisher
Jul 09, 2026

RBC Capital downgrades Bio-Techne stock rating on acquisition view By Investing.com - Investing.com Nigeria

Jul 09, 2026
pulisher
Jul 09, 2026

RBC Capital downgrades Bio-Techne stock rating on acquisition view - Investing.com

Jul 09, 2026
pulisher
Jul 08, 2026

Bio-Techne Launches Expanded R&D Systems AI-Engineered Designer Protein Portfolio - Investing News Network

Jul 08, 2026
pulisher
Jul 08, 2026

Bio-Techne Corp (TECH) Q2 2026 Earnings: EPS Misses Estimates, Stock Slips SlightlyHealthcare Earnings Report - DonanımHaber

Jul 08, 2026
pulisher
Jul 08, 2026

Bio-Techne expands AI-engineered protein portfolio for cell therapy - Investing.com

Jul 08, 2026
pulisher
Jul 08, 2026

Bio-Techne expands AI-engineered protein portfolio for cell therapy By Investing.com - Investing.com UK

Jul 08, 2026
pulisher
Jul 08, 2026

Bio-Techne expands designer proteins for cell therapy and organoids - Stock Titan

Jul 08, 2026
pulisher
Jul 08, 2026

Bio-Techne Corp : RBC Cuts to Sector Perform - Moomoo

Jul 08, 2026
pulisher
Jul 07, 2026

Form DEF 14A Bio-Techne Corp For: 7 July By Investing.com - Investing.com Canada

Jul 07, 2026
pulisher
Jul 06, 2026

Halper Sadeh LLC is Investigating Whether ACA, TECH, IRDM, LCII are Obtaining Fair Deals for their Shareholders - GlobeNewswire Inc.

Jul 06, 2026
pulisher
Jul 06, 2026

Activist investor Ananym urges Bio-Techne to consider selling - MSN

Jul 06, 2026
pulisher
Jul 05, 2026

April McClain Delaney Makes Significant Trades in Bio-Techne Corp, C.H. Robinson Worldwide, and Transdigm Group - Investing.com

Jul 05, 2026
pulisher
Jul 04, 2026

Bio-Techne will be sold for $11.3B, one of largest deals in Minnesota history - MSN

Jul 04, 2026
pulisher
Jul 03, 2026

Merck KGaA to acquire Bio-Techne in $11.3 billion deal - qz.com

Jul 03, 2026
pulisher
Jul 02, 2026

Bio-Techne Corp (TECH) Q2 2026 Earnings: EPS Misses Estimates, Stock Eases LowerCost Structure Review - dars.gov.et

Jul 02, 2026
pulisher
Jul 02, 2026

Bio-Techne Corp (TECH) Q2 2026 Earnings: EPS Misses Estimates Amidst Cautious Demand EnvironmentDividend Cut Risk - dars.gov.et

Jul 02, 2026
pulisher
Jul 02, 2026

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Bio-Techne (TECH), Concentra Group Holdings Parent, Inc. (CON) and Palvella Therapeutics (PVLA) - The Globe and Mail

Jul 02, 2026
pulisher
Jul 01, 2026

List of 18 Acquisitions by Bio-Techne (Jul 2026) - Tracxn

Jul 01, 2026
pulisher
Jun 30, 2026

Donald TrumpBIO TECHNE CORP COM UNSOLICITED Trump Trade on Mar. 23, 2026 - Quiver Quantitative

Jun 30, 2026
pulisher
Jun 30, 2026

TECH Downgraded by Benchmark -- Rating Changed to Hold - GuruFocus

Jun 30, 2026
pulisher
Jun 30, 2026

TECH Downgraded by TD Cowen -- Price Target Raised to $73.00 - GuruFocus

Jun 30, 2026
pulisher
Jun 29, 2026

$64.99 support anchors Bio-Techne stock near current levels - Traders Union

Jun 29, 2026
pulisher
Jun 29, 2026

Germany’s Merck to acquire Bio-Techne in $11.3 billion deal - MSN

Jun 29, 2026
pulisher
Jun 29, 2026

Merck KGaA to acquire U.S.-based Bio-Techne Corp. for $11.3 billion - chemengonline.com

Jun 29, 2026
pulisher
Jun 29, 2026

TECH Downgraded by Citigroup -- Rating Changed to Neutral - GuruFocus

Jun 29, 2026
pulisher
Jun 29, 2026

Merck KGaA inks $11.3bn buy of Bio-Techne in largest deal in a decade - BioXconomy

Jun 29, 2026
pulisher
Jun 29, 2026

German conglomerate Merck buys Minnesota firm Bio-Techne for $11.3B, one of largest deals in state history - Times West Virginian

Jun 29, 2026
pulisher
Jun 28, 2026

Is Bio-Techne stock underperforming the S&P 500? - MSN

Jun 28, 2026
pulisher
Jun 28, 2026

Germany's Merck to buy Bio-Techne for $73 per share - MSN

Jun 28, 2026
pulisher
Jun 28, 2026

Germany's Merck to buy Bio-Techne for $11.3 billion - MSN

Jun 28, 2026
pulisher
Jun 28, 2026

Bio-Techne Corp (TECH) Q1 2026 Earnings: EPS Falls Short of Estimates, Stock Edges HigherEarnings Momentum Score - dars.gov.et

Jun 28, 2026
pulisher
Jun 27, 2026

Germany's Merck boosts life sciences business with $11 billion Bio-Techne deal - MSN

Jun 27, 2026
pulisher
Jun 27, 2026

Price to sales forward of Bio-Techne Corp – NASDAQ:TECH - TradingView

Jun 27, 2026
pulisher
Jun 27, 2026

Price to book forward of Bio-Techne Corp – NASDAQ:TECH - TradingView

Jun 27, 2026
pulisher
Jun 27, 2026

Merck KGaA Strikes USD 11.3 Billion Bio-Techne Acquisition to Expand Life Sciences Portfolio - Medical Dialogues

Jun 27, 2026
pulisher
Jun 27, 2026

Bio-Techne Soars Over 20% on Merck Acquisition News - Intellectia AI

Jun 27, 2026
pulisher
Jun 27, 2026

Enterprise value to EBIT forward of Bio-Techne Corp – NASDAQ:TECH - TradingView

Jun 27, 2026
pulisher
Jun 27, 2026

Price to earnings forward of Bio-Techne Corp – NASDAQ:TECH - TradingView

Jun 27, 2026

Bio Techne Corp (TECH) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$91.09
price up icon 1.97%
$118.87
price up icon 1.02%
$34.72
price down icon 0.83%
$58.73
price down icon 0.17%
ONC ONC
$325.90
price up icon 0.00%
$278.40
price up icon 2.44%
大文字化:     |  ボリューム (24 時間):